Publication | Closed Access
Serum Half-Life of CA 125 during Early Chemotherapy as an Independent Prognostic Variable for Patients with Advanced Epithelial Ovarian Cancer: Results of a Multicentric Italian Study
89
Citations
0
References
1995
Year
Ca 125MedicinePathologyGynecologyMetronomic ChemotherapyCancer TreatmentSerum Half-lifeOncologyMulticentric Italian StudyGynecology OncologyOvarian Cancer
No additional data available for this publication yet. Check back later!